← Back to Search

Dance Classes for Alzheimer's Disease (IGROOVE Trial)

N/A
Recruiting
Led By Christina Hugenschmidt, PhD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, month 1, month 3, month 6
Awards & highlights

Summary

This trial is testing whether dancing can help improve memory for older adults, and how often it needs to be done to be effective.

Who is the study for?
This trial is for people aged 65+ who are worried about memory loss but don't have cognitive impairment. They must speak English, be low-active, able to do exercise tests, and have a MoCA score ≥21. Participants need reliable transport (provided if necessary) and must be MRI compatible.
What is being tested?
The study examines how dance movement and music appreciation classes affect memory and fitness in older adults at risk for Alzheimer's. Over six months, participants will attend either one, two or three weekly classes alongside clinical assessments including brain MRIs.
What are the potential side effects?
Since the interventions involve non-invasive activities like dance and music classes, side effects may include typical physical activity-related issues such as muscle soreness or fatigue. However, specific risks related to these activities aren't detailed.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, month 1, month 3, month 6
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, month 1, month 3, month 6 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Peak Oxygen Consumption (VO2)
Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)
Secondary study objectives
Class Attendance
Exercise Self-Efficacy
Other study objectives
Average Heart Rate
Brief Psychological Needs Satisfaction and Frustration Scale (BPNSFS)--Frustration
Brief Psychological Needs Satisfaction and Frustration Scale (BPNSFS)--Satisfaction
+7 more

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Dance 3 Times Weekly (3xD)Experimental Treatment1 Intervention
Participants in this arm will attend classes 3 times a week for 24 weeks. During the 24 weeks, four different dance forms will be practiced. Each dance form will be taught for 6 weeks.
Group II: Dance 2 Times Weekly (2xD)Experimental Treatment1 Intervention
Participants in this arm will attend classes 2 times a week for 24 weeks. During the 24 weeks, four different dance forms will be practiced. Each dance form will be taught for 6 weeks.
Group III: Dance 1 Time Weekly (1xD)Experimental Treatment1 Intervention
Participants in this arm will attend a class 1 time a week for 24 weeks. During the 24 weeks, four different dance forms will be practiced. Each dance form will be taught for 6 weeks.
Group IV: Music Appreciation Classes (MAC)Active Control1 Intervention
In the MAC, the music associated with that dance form will be used as the subject for classes and will also change every 6 weeks.

Find a Location

Who is running the clinical trial?

National Institute on Aging (NIA)NIH
1,733 Previous Clinical Trials
28,054,843 Total Patients Enrolled
Wake Forest University Health SciencesLead Sponsor
1,266 Previous Clinical Trials
1,013,547 Total Patients Enrolled
Christina Hugenschmidt, PhDPrincipal InvestigatorWake Forest University Health Sciences
2 Previous Clinical Trials
116 Total Patients Enrolled

Media Library

Dance Classes Clinical Trial Eligibility Overview. Trial Name: NCT05507905 — N/A
Alzheimer's Disease Research Study Groups: Dance 1 Time Weekly (1xD), Dance 2 Times Weekly (2xD), Dance 3 Times Weekly (3xD), Music Appreciation Classes (MAC)
Alzheimer's Disease Clinical Trial 2023: Dance Classes Highlights & Side Effects. Trial Name: NCT05507905 — N/A
Dance Classes 2023 Treatment Timeline for Medical Study. Trial Name: NCT05507905 — N/A
Alzheimer's Disease Patient Testimony for trial: Trial Name: NCT05507905 — N/A
~101 spots leftby Mar 2027